发明申请
- 专利标题: Drug Release From Nanoparticle-Coated Capsules
- 专利标题(中): 纳米颗粒涂层胶囊释放药物
-
申请号: US13073351申请日: 2011-03-28
-
公开(公告)号: US20110229559A1公开(公告)日: 2011-09-22
- 发明人: Clive Allan Prestidge , Spomenka Simovic , Nasrin Ghouchi Eskandar
- 申请人: Clive Allan Prestidge , Spomenka Simovic , Nasrin Ghouchi Eskandar
- 申请人地址: AU Adelaide
- 专利权人: University of South Australia
- 当前专利权人: University of South Australia
- 当前专利权人地址: AU Adelaide
- 优先权: AU2006902311 20060504; AU2006906840 20061207
- 主分类号: A61K9/127
- IPC分类号: A61K9/127 ; A61K9/00 ; A61K31/07 ; A61P3/02 ; B82Y5/00
摘要:
Methods of producing a controlled release formulation for an active substance are disclosed, wherein the methods involve dispersing a discontinuous phase comprising an active substance into a continuous phase so as to form a two-phase liquid system comprising droplets of said discontinuous phase, and allowing nanoparticles provided to the two-phase liquid system to congregate at the phase interface to thereby coat the surface of the droplets in at least one layer of said nanoparticles. The methods utilise a concentration of a suitable electrolyte which enhances the nanoparticle congregation such that the coating of nanoparticles on the surface of the droplets presents a semi-permeable barrier to the active substance, or otherwise utilise a amount of the active substance that is greater than the solubility limit of that active substance in the discontinous phase. Formulations comprising vitamin A (retinol) as the active substance for dermal delivery are specifically exemplified.
信息查询